Lyfegen

Lyfegen HealthTech AG is a global Software-as-a-Service (SaaS) provider based in Basel, Switzerland, with a focus on enhancing drug access, pricing, contracting, and rebate managem

ent in the healthcare sector. Founded in October 2018, the company operates as a neutral intermediary between healthcare payers and pharmaceutical manufacturers, promoting value-based and outcome-based healthcare models. Lyfegen offers a range of services, including value-based contracting implementation, drug pricing agreement modeling, rebate management optimization, and data analytics. Its proprietary platform utilizes advanced technology, such as machine learning and real-world data, to automate complex pricing agreements and improve financial governance. The company also recently launched the AI Contracting Companion, a generative AI tool designed to streamline drug contracting processes and enhance patient access. With a strong presence in Europe, North America, and the Middle East, Lyfegen serves various stakeholders, including pharmaceutical companies, healthcare payers, MedTech firms, and hospitals, all aimed at making healthcare treatments more affordable and accessible.